glp 1 vs glp2 2 glp Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Innovative Glucagon-based Therapies for Obesity
Description
UPDATE 3-US FDA sees pancreatitis link with Merck's Januvia [article online], Reuters, 25 September 2009
PMID: 40508146
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the surmount-4 randomized clinical trial
In both mice and rats, administration of ICV exendin-4(939) (Ex9), a potent GLP-1r antagonist, during oral glucose impairs glucose tolerance and reduces insulin levels (104, 209, 229)
